---
figid: PMC3928074__nihms550827f1
figlink: /pmc/articles/PMC3928074/figure/F1/
number: F1
caption: Figure shows scheme of VEGF receptor signaling pathway in CLL as well as
  aspects of pathway targeted by bevacizumab, AZD2171, and sunitinib malate.
pmcid: PMC3928074
papertitle: Phase II Trials of Single Agent Anti-VEGF Therapy for Patients with Chronic
  Lymphocytic Leukemia (CLL).
reftext: Tait Shanafelt, et al. Leuk Lymphoma. ;51(12):2222-2229.
pmc_ranked_result_index: '32734'
pathway_score: 0.9557571
filename: nihms550827f1.jpg
figtitle: Phase II Trials of Single Agent Anti-VEGF Therapy for Patients with Chronic
  Lymphocytic Leukemia (CLL)
year: ''
organisms: Homo sapiens
ndex: 487e74c0-dee7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3928074__nihms550827f1.html
  '@type': Dataset
  description: Figure shows scheme of VEGF receptor signaling pathway in CLL as well
    as aspects of pathway targeted by bevacizumab, AZD2171, and sunitinib malate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT3
  - SETD2
  - EP300
  - VEGFA
  - DLK1
  - MCL1
  - VEGFC
  - VEGFD
  - BCL2L1
  - PGF
  - MYC
  - VEGFB
  - XIAP
  - ARNT
  - CCND1
  - AZD2171
  - Ser
genes:
- word: STAT-3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: p300
  symbol: p300
  source: hgnc_alias_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: D1,C-myc,
  symbol: Delta1
  source: hgnc_alias_symbol
  hgnc_symbol: DLK1
  entrez: '8788'
- word: Mcl-1,
  symbol: Mcl-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: CyclinD1,C-myc,Bcl-X
  symbol: Bcl-X
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: D1,C-myc,
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: XIAP,
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: ARNT
  symbol: ARNT
  source: hgnc_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: CyclinD1,C-myc,Bcl-X
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
chemicals:
- word: AZD2171
  source: MESH
  identifier: C500926
- word: Ser
  source: MESH
  identifier: D012694
diseases: []
figid_alias: PMC3928074__F1
redirect_from: /figures/PMC3928074__F1
figtype: Figure
---
